🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 11% of ingredients have research evidence
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

2 Softgel(s) Serving Size
90 Servings
Fat/Fatty Acid Product Type
11% Evidence Coverage

Supplement Facts — Evidence Check

Total Fat
2.5 Gram(s) (4% DV)
Saturated Fat
0.5 Gram(s) (4% DV)
Polyunsaturated Fat
1 Gram(s)
Monounsaturated Fat
0.5 Gram(s)
Cholesterol
15 mg (6% DV)
Protein
1 Gram(s) (1% DV)
2.4 Gram(s)
📊 Market median: 750.0mg (447 products) 📚 388 studies (Tier A: 18, B: 204)
This product: 2.4mg UL 3000mg
Calories
25 Calorie(s)
Calories from Fat
20 Calorie(s)

Other Ingredients

Gelatin Glycerin Mixed Tocopherols

Label Claims — Verification

Nutrient
Structure/Function
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

As a dietary supplement for adults, take two (2) softgel two to three times daily with meals of your choice.

⚠️ Warnings & Precautions

Contains Fish IngredientsAnchovy, Mackerel, Sardine

🧪 Formulation Notes

- Contains omega-3

- Purified to eliminate mercury, PCBs and dioxins

Contains Fish IngredientsAnchovy, Mackerel, Sardine

WITH 360 mg OF OMEGA-3 PER SOFTGEL

PURIFIED TO ELIMINATE MERCURY, PCB'S & DIOXINS

GLUTEN FREE

Additional Information

- Laboratory tested to release nutrient within 15 minutes

100% satisfaction guaranteed.

Store at room temperature, tightly closed.

HEART HEALTH

Product Details

DSLD Entry Date 2015-04-24
Product Type Fat/Fatty Acid
Form Softgel Capsule
DSLD ID 44721
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →